As illustrated in Figure 5B, in the HCC datasets, we identified a total of four outlier samples, which include NAT samples HCC.314P and HCC.12287P, as well as tumor samples HCC.424 T and HCC.1240 T (P-value <0.001, Table S5). This evidence concerns the gene BRD2 and hepatocellular carcinoma.